[{"symbol": "PRAX", "price": 317.25, "beta": 2.881, "volAvg": 845150, "mktCap": 6707186242, "lastDiv": 0, "range": "26.7-326.91", "changes": 19.50999, "companyName": "Praxis Precision Medicines, Inc.", "currency": "USD", "cik": "0001689548", "isin": "US74006W2070", "cusip": "74006W108", "exchange": "NASDAQ Global Select", "exchangeShortName": "NASDAQ", "industry": "Biotechnology", "website": "https://www.praxismedicines.com", "description": "Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and PRAX-944, a selective small molecule inhibitor of T-type calcium channels, which is in Phase IIa clinical trial for the treatment of essential tremor. The company is also developing PRAX-562, a persistent sodium current blocker that is in Phase I clinical trial to treat severe pediatric epilepsy and adult cephalgia; PRAX-222, an antisense oligonucleotide (ASO) for patients with gain-of-function (GOF) SCN2A epilepsy; and KCNT1 program for the treatment of KCNT1 GOF epilepsy. It has a cooperation and license agreement with RogCon Inc.; a license agreement with Purdue Neuroscience Company; a research collaboration, option, and license agreement with Ionis Pharmaceuticals, Inc.; and collaboration with The Florey Institute to develop three novel ASOs. The company was incorporated in 2015 and is based in Boston, Massachusetts.", "ceo": "Marcio Silva De'Souza", "sector": "Healthcare", "country": "US", "fullTimeEmployees": "116", "phone": "617 300 8460", "address": "99 High Street", "city": "Boston", "state": "MA", "zip": "02110", "dcfDiff": 303.88557, "dcf": 13.36443447495356, "image": "https://images.financialmodelingprep.com/symbol/PRAX.png", "ipoDate": "2020-10-16", "defaultImage": false, "isEtf": false, "isActivelyTrading": true, "isAdr": false, "isFund": false}]